Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
Novel immunotherapy has revolutionized the landscape of cancer therapy in multiple tumor types since Ipilimumab, the first ICB agent, was approved for the treatment of metastatic melanoma is 2011.
Historical Prices for Global X Data Center & Digital Infrastructure ETF Sustainability Rating Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results